U.S. flag

An official website of the United States government

NM_006745.5(MSMO1):c.519T>A (p.His173Gln) AND Microcephaly-congenital cataract-psoriasiform dermatitis syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 1, 2011
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000208581.2

Allele description [Variation Report for NM_006745.5(MSMO1):c.519T>A (p.His173Gln)]

NM_006745.5(MSMO1):c.519T>A (p.His173Gln)

Gene:
MSMO1:methylsterol monooxygenase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q32.3
Genomic location:
Preferred name:
NM_006745.5(MSMO1):c.519T>A (p.His173Gln)
HGVS:
  • NC_000004.12:g.165338766T>A
  • NG_042288.1:g.16101T>A
  • NM_001017369.3:c.126T>A
  • NM_006745.5:c.519T>AMANE SELECT
  • NP_001017369.1:p.His42Gln
  • NP_006736.1:p.His173Gln
  • NC_000004.11:g.166259918T>A
  • NM_006745.4:c.519T>A
  • Q15800:p.His173Gln
Protein change:
H173Q; HIS173GLN
Links:
UniProtKB: Q15800#VAR_076532; OMIM: 607545.0001; dbSNP: rs869025576
NCBI 1000 Genomes Browser:
rs869025576
Molecular consequence:
  • NM_001017369.3:c.126T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006745.5:c.519T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Microcephaly-congenital cataract-psoriasiform dermatitis syndrome
Synonyms:
SC4MOL DEFICIENCY; Microcephaly, congenital cataract, and psoriasiform dermatitis
Identifiers:
MONDO: MONDO:0014793; MedGen: C5567510; OMIM: 616834

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000264351OMIM
no assertion criteria provided
Pathogenic
(Mar 1, 2011)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Mutations in the human SC4MOL gene encoding a methyl sterol oxidase cause psoriasiform dermatitis, microcephaly, and developmental delay.

He M, Kratz LE, Michel JJ, Vallejo AN, Ferris L, Kelley RI, Hoover JJ, Jukic D, Gibson KM, Wolfe LA, Ramachandran D, Zwick ME, Vockley J.

J Clin Invest. 2011 Mar;121(3):976-84. doi: 10.1172/JCI42650.

PubMed [citation]
PMID:
21285510
PMCID:
PMC3049385

Details of each submission

From OMIM, SCV000264351.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a 15-year-old girl with microcephaly, congenital cataracts, severe psoriasiform dermatitis, and elevated methylsterols (MCCPD; 616834), He et al. (2011) identified compound heterozygosity for 2 mutations in the SC4MOL gene: a c.519T-A transversion (c.519T-A, NM_006745) in exon 4, resulting in a his173-to-gln (H173Q) substitution, and a c.731A-G transition in exon 6 of the SC4MOL gene, resulting in a tyr244-to-cys (Y244C; 607545.0002) substitution. Both substitutions are located at highly conserved residues, within the second and fourth metal-binding domains, respectively. Each parent was heterozygous for 1 of the mutations, which were not found in 2,876 alleles from population controls or in the dbSNP or 1000 Genomes Project databases. Plasma methylsterol levels were increased in the parents, though to a lesser degree than in the patient, suggesting a subclinical effect in the heterozygous state. Analysis of cell proliferation in patient fibroblasts showed increased cell division compared to control cells when cultured in cholesterol-restricted medium. Immunologic analysis revealed that activated CD16+ (146740) granulocytes were increased 30- and 20-fold in the patient and her father, respectively, compared to controls. In addition, there were 30- and 15-fold increases in the numbers of TLR2+ (603028)/TLR4- (603030) granulocytes in the patient and her father. He et al. (2011) noted that upregulation of TLR2 but not TLR4 was typical in patients with psoriasis or psoriatic arthritis and stated that it likely reflects dysregulation of the immune response following normal bacterial infections. Expression of the granulocyte-specific CD16B (610665) isoform was also markedly downregulated in the patient and her father, suggesting a defect in phagocytic function. Serum cytokine profiles showed that the levels of a number of proinflammatory cytokines and chemokines associated with granulocyte and monocyte activation were increased in the patient, and to a lesser extent in her father.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 19, 2022